Last 31 quarters of trend data · Healthcare · Drug Distributors & Pharmacies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 1.27 | — | — | 1.43 | 1.31 | — | — | 6.96 | 3.00 | — | — | 10.00 | 3.11 | — | — | 9.83 | 1.20 | — | — | — | — |
| — | — | — | -79.4% | -56.5% | — | — | -30.4% | -3.6% | — | — | +1.8% | +159.5% | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.05 | 0.07 | 0.12 | 0.07 | 0.12 | 0.28 | 0.32 | 0.35 | 0.33 | 0.32 | 0.38 | 0.23 | 0.14 | 0.21 | 0.37 | 0.30 | 0.09 | 0.19 | 0.75 | 0.42 | 1.91 |
| — | -75.0% | -61.3% | -80.5% | -63.0% | -12.5% | -16.1% | +53.5% | +129.8% | +50.3% | +3.3% | -25.4% | +63.6% | +13.7% | -51.0% | -27.1% | -95.4% | -94.5% | -82.3% | -90.9% | -20.4% | |
| P/B Ratio | 0.14 | 0.12 | 0.24 | 0.18 | 0.42 | 0.67 | 0.76 | 1.02 | 1.94 | 1.37 | 1.47 | 0.99 | 0.69 | 0.62 | 0.94 | 0.93 | 0.29 | 0.34 | 1.04 | 0.92 | 3.02 |
| — | -81.6% | -68.0% | -82.7% | -78.3% | -51.5% | -48.1% | +3.5% | +181.4% | +121.9% | +56.7% | +5.9% | +135.7% | +83.4% | -10.1% | +1.0% | -90.3% | -89.9% | -78.2% | -87.4% | -44.3% | |
| P/FCF | 3.05 | — | — | 0.61 | 34.66 | — | — | 2.03 | — | — | 6.13 | 2.00 | — | — | — | 1.51 | — | — | — | 9.21 | — |
| — | — | — | -70.1% | — | — | — | +1.2% | — | — | — | +32.8% | — | — | — | -83.6% | — | — | — | -70.6% | — | |
| EV / EBITDA | 4.28 | — | 18.39 | 2.96 | 2.19 | — | — | 8.45 | 4.48 | — | 56.64 | 6.39 | 3.86 | — | — | 6.13 | 3.34 | — | — | 27.90 | — |
| — | — | — | -64.9% | -51.1% | — | — | +32.1% | +16.0% | — | — | +4.3% | +15.5% | — | — | -78.0% | — | — | — | +27.5% | — | |
| EV / EBIT | 6.23 | — | 8.26 | 3.32 | 1.86 | — | 9.51 | 4.14 | 5.38 | — | — | 7.69 | 4.28 | — | — | 7.47 | 3.80 | — | — | 108.91 | — |
| — | — | -13.1% | -20.0% | -65.5% | — | — | -46.1% | +25.9% | — | — | +3.0% | +12.5% | — | — | -93.1% | — | — | — | +328.6% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.6% | 22.5% | -91.5% | 40.9% | 116.7% | 20.4% | 30.1% | 40.8% | 46.5% | 33.2% | 39.7% | 49.4% | 52.7% | 32.7% | 38.3% | 52.7% | 55.6% | 33.8% | 21.5% | 57.8% | 24.6% |
| — | +10.5% | -403.7% | +0.2% | +151.0% | -38.7% | -24.2% | -17.4% | -11.8% | +1.4% | +3.8% | -6.4% | -5.2% | -3.2% | +77.9% | -8.7% | +125.8% | -18.0% | -67.4% | -20.9% | -67.8% | |
| Operating Margin | 4.6% | -8.8% | 0.9% | 8.5% | 14.0% | -12.4% | -3.6% | 5.4% | 14.7% | -4.1% | -0.5% | 8.8% | 13.6% | -9.6% | -16.1% | 11.3% | 16.6% | -24.3% | -89.2% | 0.8% | -89.4% |
| — | +28.7% | +124.0% | +57.0% | -4.9% | -202.4% | -701.4% | -38.5% | +8.1% | +57.5% | +97.2% | -22.0% | -17.9% | +60.4% | +82.0% | +1225.8% | +118.6% | +32.2% | -1303.6% | -95.8% | -359.0% | |
| Net Margin | 3.8% | -7.3% | -5.2% | 9.3% | 12.9% | -9.3% | 3.7% | 6.4% | 11.1% | -15.2% | -10.1% | 2.3% | 4.8% | -13.3% | -21.6% | 3.1% | 7.1% | -26.1% | -78.4% | -2.6% | -70.8% |
| — | +21.7% | -240.4% | +46.3% | +16.6% | +39.2% | +136.9% | +180.6% | +131.4% | -14.2% | +53.2% | -26.6% | -32.2% | +49.0% | +72.5% | +220.8% | +110.0% | +15.4% | -4558.3% | -119.3% | -381.8% |
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.1% | -3.2% | -2.6% | 6.3% | 11.9% | -5.4% | 2.3% | 5.9% | 17.9% | -15.2% | -9.3% | 2.5% | 5.9% | -9.4% | -13.0% | 2.4% | 6.1% | -11.4% | -24.1% | -1.4% | -24.4% |
| — | +41.6% | -212.9% | +6.4% | -33.6% | +64.3% | +124.3% | +135.3% | +201.2% | -62.4% | +27.9% | +4.4% | -2.6% | +17.7% | +46.2% | +268.7% | +125.0% | -53.2% | -4963.4% | -126.3% | -260.3% | |
| ROA | 4.5% | -1.5% | -1.2% | 3.0% | 5.4% | -2.5% | 1.0% | 2.0% | 4.4% | -3.8% | -2.5% | 0.7% | 1.6% | -2.6% | -3.8% | 0.7% | 1.8% | -3.3% | -7.8% | -0.5% | -9.7% |
| — | +41.0% | -216.6% | +48.0% | +23.4% | +34.8% | +139.8% | +193.2% | +172.3% | -46.4% | +33.3% | -3.8% | -8.8% | +22.3% | +51.4% | +246.9% | +118.2% | +2.4% | -3484.2% | -118.7% | -228.3% | |
| ROIC | 5.6% | -1.8% | 0.2% | 2.6% | 5.6% | -3.2% | -1.0% | 1.7% | 5.3% | -0.9% | -0.1% | 2.4% | 4.1% | -1.7% | -2.6% | 2.4% | 3.8% | -2.9% | -8.9% | 0.2% | -13.0% |
| — | +43.4% | +120.2% | +55.2% | +6.6% | -247.1% | -873.3% | -29.3% | +29.7% | +45.6% | +96.1% | -0.5% | +6.6% | +42.7% | +70.5% | +1339.2% | +129.3% | +35.4% | -822.4% | -96.7% | -196.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.61 | 0.65 | 0.61 | 0.61 | 0.74 | 0.77 | 0.72 | 0.76 | 2.27 | 2.63 | 2.25 | 2.06 | 2.15 | 2.29 | 2.11 | 1.86 | 1.91 | 2.05 | 1.91 | 1.50 | 1.52 |
| — | -15.8% | -15.3% | -19.8% | -67.5% | -70.7% | -67.9% | -63.2% | +5.6% | +14.8% | +6.8% | +10.4% | +12.6% | +12.2% | +10.7% | +23.8% | +25.5% | +156.8% | +151.5% | +100.3% | +171.7% | |
| Debt / EBITDA | 4.34 | — | 54.67 | 9.85 | 5.75 | — | — | 15.66 | 9.74 | — | 142.33 | 17.93 | 11.83 | — | — | 17.86 | 12.12 | — | — | 82.91 | — |
| — | — | — | -37.1% | -41.0% | — | — | -12.7% | -17.7% | — | — | +0.4% | -2.4% | — | — | -78.5% | — | — | — | +845.8% | — | |
| Current Ratio | 1.82 | 2.00 | 1.82 | 1.59 | 1.81 | 1.54 | 1.60 | 1.86 | 1.92 | 1.84 | 1.91 | 2.02 | 2.11 | 2.49 | 2.65 | 2.62 | 2.46 | 2.60 | 3.55 | 3.71 | 4.10 |
| — | +29.7% | +13.7% | -14.5% | -5.5% | -16.4% | -16.0% | -8.0% | -9.1% | -26.2% | -27.9% | -22.8% | -14.4% | -4.2% | -25.4% | -29.3% | -40.0% | -24.6% | -20.1% | -27.8% | +21.4% | |
| Quick Ratio | 1.82 | 2.00 | 1.82 | 1.59 | 1.81 | 1.54 | 1.60 | 1.86 | 1.92 | 1.84 | 1.86 | 2.07 | 2.11 | 2.49 | 2.61 | 2.62 | 2.46 | 2.60 | 3.50 | 3.71 | 4.10 |
| — | +29.7% | +13.7% | -14.5% | -5.5% | -16.4% | -13.7% | -10.0% | -9.1% | -26.2% | -28.7% | -21.1% | -14.4% | -4.2% | -25.5% | -29.3% | -40.0% | -24.6% | -21.2% | -27.8% | +21.4% | |
| Interest Coverage | 2.71 | -2.26 | 1.54 | 3.45 | 8.09 | -2.19 | 1.77 | 2.70 | 2.67 | -0.52 | -0.06 | 1.36 | 2.26 | -1.05 | -1.64 | 1.59 | 2.52 | -2.35 | -9.90 | 0.19 | -16.41 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 31 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SLQT stock.
SelectQuote, Inc.'s current P/E is 1.3x. The average P/E over the last 2 quarters is 1.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SelectQuote, Inc.'s current operating margin is 4.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SelectQuote, Inc.'s business trajectory between earnings reports.